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KARA GRASSO VEEDER. A Study of the Management of Opioid Prescriptions Among 
Patients with a History of Substance Abuse. (Under the direction of DR. RENATA 
LEITE). 
Prescription opioid abuse is the fastest-growing drug problem in the 
United States and has been declared an epidemic by the U.S. White House Office of 
National Drug Control Policy. Immediate release (IR) opioids, especially 
hydrocodone and oxycodone, are abused or misused most commonly. Dentists are 
only second to family physicians in the number of IR opioid prescriptions written. 
Just under te n percent of the population in the United States in 2010 were classified 
with substance dependence or abuse in 2009. This study poses the following 
questions: 1. Do patients with a personal or family history of substance abuse 
manage prescription opioids differently than patients without a personal or family 
history of substance abuse? 2. Are they more or less likely to lend, borrow, save 
and/or properly dispose of leftover pills? 3. Do differences exist between their pre-
knowledge and post-knowledge of prescription safety behaviors after going through 
a prescription safety intervention? 
Opioid analgesics were prescribed to sixty-two consenting adult outpatients 
treated at the Medical University of South Carolina Post-Doctoral Periodontic 
program or at the pain management clinic. Participants completed a brief, 
interactive, patient-tailored, web-based Script Safety intervention, which provided 
patient education regarding the hazards of prescription opioid misuse} and safe use, 
storage and disposal of prescription opioids. At one-week and one-month post 
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intervention, participants were contacted via telephone to assess knowledge change 
and/ or retention, medication misuse behaviors, and patient satisfaction. 
Forty-eight point four percent (N =30) of participants qualified for a positive 
personal or familial history of addiction. Participants with a positive history of 
addiction were more likely than chance to lend their prescriptions to other people. 
These participants were also more likely to borrow pills from other people. 
Therefore, identification of these patients is essential for the dental community to 
offer proper counseling and prescribing practices tailored to their individual needs. 
In doing so, it is likely that fewer drugs will be diverted. 
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INTRODUCTION 
Prescription opioid abuse is the fastest-growing drug problem in the United 
States and has been declared an epidemic by the U.s. White House Office of National 
Drug Control Policy.! The Journal of the American Dental Association featured a 
cover story examining the dentist's role in preventing prescription opioid abuse.2 
Analgesics are classified as opioids and non-opioids.3 Opioids activate specific 
receptors in an identical manner as that of an opiate, such as morphine.3 The non-
medical use, abuse and dependence on prescription opioids have grown alarmingly 
over the last 10 years and are a public health concern.1. 4,5 The combination of 
hydrocodone/acetaminophen is the most prescribed medication of any category of 
drug, exceeding statins and antibiotics.6 Among teens, opiate analgesics are among 
the most commonly used drugs with hydrocodone being the second most abused 
drug surpassed only by marijuana.7, 8 
Non-medical use of opioids falls into two categories: misuse and abuse. 
Misuse is use of a medication (prescribed for a medical purpose) other than as 
directed or as indicated, whether willfully or unintentionally, and whether or not 
harm results from use.9, 10 Abuse is defined as any use of an illegal drug or the 
intentional self-administration of a medication for a nonmedical purpose such as 
altering one's state of consciousness.9, 10 Addiction is a pathological, behavioral 
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syndrome characterized in part by cravings for, loss of control over, and inability to 
abstain from opioids.11 According to the American Psychiatric Association's 
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV TR)J the definition 
for substance abuse is more specific and is defined as a maladaptive pattern of 
substance use leading to clinically significant impairment or distress as manifested 
by one (or more) of the following, occurring within a 12-month period: 1. Recurrent 
substance use resulting in a failure to fulfill major role obligations at work, school, 
or home (such as repeated absences or poor work performance related to substance 
use; substance-related absences, suspensions, or expulsions from school; or neglect 
of children or household); 2. Recurrent substance use in situations in which it is 
physically hazardous (such as driving an automobile or operating a machine when 
impaired by substance use); 3. Recurrent substance-related legal problems (such as 
arrests for substance related disorderly conduct); 4. Continued substance use 
despite having persistent or recurrent social or interpersonal problems caused or 
exacerbated by the effects of the substance (for example, arguments with spouse 
about consequences of intoxication and physical fights).12 This differs from 
substance dependence which is accepted to be a maladaptive pattern of substance 
use leading to clinically significant impairment or distress, as manifested by three 
(or more) of the following, occurring any time in the same 12-month period: 1. 
Tolerance, as defined by either of the following: (a) a need for markedly increased 
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amounts of the substance to achieve intoxication or the desired effect; (b) markedly 
diminished effect with continued use of the same amount of the substance; 2. 
Withdrawal, as manifested by either of the following: (a) the characteristic 
withdrawal syndrome for the substance; (b) the same (or closely related) substance 
is taken to relieve or avoid withdrawal symptoms; 3. The substance is often taken in 
larger amounts or over a longer period than intended; 4. There is a persistent 
desire or unsuccessful efforts to cut down or control substance use; S. A great deal 
of time is spent in activities necessary to obtain the substance, use the substance, or 
recover from its effects; 6. Important social, occupational, or recreational activities 
are given up or reduced because of substance use; 7. The substance use is continued 
despite knowledge of having a persistent physical or psychological problem that is 
likely to have been caused or exacerbated by the substance (for example, current 
cocaine use despite recognition of cocaine .. induced depression or continued 
drinking despite recognition that an ulcer was made worse by alcohol 
consumption ).12 
Immediate release (IR) opioids, especially hydrocodone and oxycodone, are 
abused or misused most commonly. In the United States, dentists are only second to 
family physicians in the number of IR opioid prescriptions written.8, 13 Emergency 
department visits associated with nonmedical opioid use have dramatically 
increased between 2004 and 2008.14 The National Survey on Drug Use and Health 
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(NSDUH) from 2009 determined that millions of people age 12 and older used 
psychotherapeutic medications non-medically for the first time in the preceding 
year, the majority of whom used pain relievers. The majority of those pain relievers 
were acquired through a friend or family member for free, some were bought from a 
friend or family member, taken from a friend or family member without permission 
or acquired from a stranger or drug dealer.l, 13 It is astounding that most 
adolescents acquire their opioids for misuse or abuse from family or friends. Teens 
who report abusing controlled prescription drugs are more likely to use alcohol, 
marijuana, heroin, Ecstasy and cocaine. IS 
Focusing on people in the United States in 2010 who were 12 years of age or 
older, it was estimated that just under 10% of the population were classified with 
substance dependence or abuse in 2009.13,16 Only a small fraction of those with 
substance dependence or abuse received treatment at a specialty facility. 
Furthermore, despite the strong link between substance misuse and health related 
problems, nurses and other health care professionals have been reluctant to engage 
with this patient population.17 This may be due to lacking the proper guidance with 
regard to what the dentist should do or in part due to the fact that the dentist has no 
financial incentive to take the time to ask psychosocial or substance abuse 
questions.16 
Based on the current status of opioid misuse and the high percentage of 
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Americans with a personal or family history of substance abuse, a secondary data 
analysis was performed on data from a study done to pilot test a Script Safety 
intervention. The intervention consisted of a ttVideo Doctor" counseling session 
discussing risks, proper handling and disposal of prescription opiates. A brief 
questionnaire to assess demographics, risk factors and history of prescription drug 
misuse was used, followed by a pre-knowledge assessment. A post-intervention 
knowledge assessment at the end of the program measured comprehension of 
material delivered. Based on data gathered from the Script Safety study, it is 
prudent to ask the following questions: Do patients. with a personal or family history 
of substance abuse manage prescription opioids differently than patients without a 
personal or family history of substance abuse? Are these patients more or less likely 
to lend, borrow, save and properly dispose of leftover pills? What differences exist 
between their pre-knowledge and post-knowledge of prescription safety behaviors? 
This study seeks to answer these questions and has the potential to reduce the 
occurrence of prescription opioid misuse and abuse while encouraging physicians 
and dentists to identify patients who may be at greater risk for diversion. 
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REVIEW OF LITERATURE 
Economic costs 
In the United States, the economical cost of the nonmedical use of 
prescription opioids exceeds $50 billion annually. Seventy-nine percent of these 
costs are attributable to lost productivity, 150/0 to criminal justice, 4010 to drug abuse 
treatment and 20/0 to medical complications.18 
Growth Rate ojOpioid Abuse 
Between 1992 and 2003, abuse of controlled prescription drugs has been 
growing at a rate twice that of marijuana abuse,S times greater than cocaine abuse 
and 60 times greater than heroin.19 Immediate release (IR) opioids, especially 
hydrocodone and oxycodone, are abused or misused most commonly; dentists 
prescribe 120/0 of all IR opioid prescriptions in the United States, second only to 
family practice physicians who prescribe 150/0.8,13 More than 12 billion dosage units 
of opioids are dispensed each year in the United States; 1 to 1.5 billion of those 
doses are estimated to have been prescribed by dentists. 16 According to The Drug 
Abuse Warning Network (DAWN) administered by the Substance Abuse and Mental 
Health Services Administration (SAMHSA), there was a 111 % increase of emergency 
departments visits associated with nonmedical opioid use and a 123010 increase in 
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visits involving hydrocodone products between 2004 and 2008.14 
The National Survey on Drug Use and Health (NSDUH) conducted in 2010 
determined that 3.0 million people age 12 and older used psychotherapeutic 
medications non-medically for the first time in 2009; 2.0 million of those used pain 
relievers. Fifty-five point three percent of those pain relievers were acquired 
through a friend or family member for free; 9.9% bought them from a friend or 
family member; 5% took them from a friend or family member without permission 
and 4.8% acquired them from a stranger or drug dealer.13 Combining these data, it 
is astounding that 7 out of 10 adolescents acquire their opioids for misuse or abuse 
from family or friends'! The Monitoring the Future (MTF), in 2009, surveyed 
students in 8th, 10th and 12th grades and concluded that among 12th grade students, 
the lifetime prevalence of prescription opioid misuse was 13.20/0.8 Teens who 
report abusing controlled prescription drugs are twice as likely to use alcohol; five 
times likelier to use marijuana; 12 times likelier, heroin; 15 times likelier, Ecstasy; 
and 21 times likelier to use cocaine. IS Approximately 33% of new-users over the 
age of 12 first started with non-medical use of a prescription drug.1,13 
Focusing on people in the United States, who are 12 years of age or older, in 
2010, it was estimated that 22.1 million were classified with substance dependence 
or abuse in the preceding year, that is 8.7 percent of the population. Those classified 
with a dependence or abuse on particular substances were as follows: 2.9 million 
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on both alcohol and illicit drugs; 4.2 million on illicit drugs but not alcohol; and 15.0 
million on alcohol but not illicit drugs. Twenty three point one million persons 
needed treatment for substance dependence or abuse. Of these, only 2.6 million 
received treatment at a specialty facility.13 Abuse of prescription opioids for one 
year increases the chance of legal or medical problems by 3%; prescription opioid 
abuse for 10 years increases that chance by 34% as determined by a study of 5,686 
patients who were abusing opioids.20 
In response to the high rate of substance abuse among Americans, federal 
mental health and substance abuse treatment agencies have seen funding increase 
for many programs including substance abuse treatment and prevention for the 
second year in a row.21 Treatment initiation generally refers to beginning the 
treatment process and can include presenting for and completing an initial 
assessment and returning for follow-up contact within a specified period oftime.22, 
23 Treatment engagement has been defined by attendance at a specified number of 
treatment sessions within a specified number ofweeks.23, 24 ENREF 24 Treatment 
adherence generally refers to complying with a plan for treatment that has been 
formulated by a treatment team with a client's participation.23 Almost 20 million 
people with substance abuse or dependence went untreated in 2010.13 
Combining the number of people untreated for substance abuse or 
dependence with the number of new users misusing prescription opioids, it is 
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understandable that opiate overdoses due to prescription painkillers are 
increasing.25 In 2006, it was found that of 250 overdose-related decedents in a West 
Virginia population, 65 0/0 had died from unintentional overdose using opioid 
analgesics.26 The most significant opioid effects are mediated through mu and 
kappa receptors. Effects generated by mu receptors produce an unlimited dose 
response, but those mediated by kappa receptors have a ceiling to their effects. 
Opioids act as agonists or antagonists at these receptors.3 According to Becker, the 
mu receptor is responsible for mediating analgesia as well as respiratory depression 
and dependence. Mu effects have unlimited intensity which increase 
proportionately with dose. The kappa receptor mediates analgesia and respiratory 
depression but does not increase with greater doses. Novel compounds that act as 
agonists at kappa receptors but act as antagonists at mu receptors are called 
agonist-antagonists, produce less respiratory depression at higher doses and have 
less potential for abuse. Some recommend these as good choices for patients with a 
history of drug seeking but not for those currently dependent.3 While others 
suggest these do not provide adequate analgesia for use in patients with a history of 
substance abuse or dependency.27 
While opioid analgesia certainly has a place in dentistry, it is important to 
understand the degree of post-operative pain relief necessary. A pilot study 
investigating the use of prescription opioids among 15 patients post-implant 
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placement, illustrated that 93% of patients needed to use opioid analgesics for only 
3 days versus 5 days for impacted third molar extractions.28 Approximately 3.5 
million third-molar extractions were performed in the United States in 2006; most 
of these patients received a prescription for an opioid analgesic for post-operative 
pain. Therefore, 3.5 million patients in their early twenties were exposed to opioids 
as a result of third-molar extractions in 2006 alone.2 Dentists are cautioned to 
avoid prescribing any opioid product for patients already receiving opioids for 
chronic pain disorders and for those under treatment for opioid abuse. Rather, it is 
appropriate to request an increase in dosage from the prescribing physician if 
necessary.3 
The National Center on Addiction and Substance Abuse (CASA) surveyed 
physicians and found that 57% of doctors believe that they bear primary 
responsibility for preventing prescription drug diversion and abuse. This survey 
also reveals, however, that only 19% received training in prescription drug 
diversion in medical school, 39% in residency, and 34% through continuing medical 
education. Physicians reveal that they are not well trained to spot signs of 
substance abuse and dependence. 16, 19 In 2000, a national survey of medical 
residency programs found that only 56% required substance use disorder training 
and even then the training consisted of between 3 to 12 curricular hours.29 A focus 
group of dentists involved in the CASA survey concluded that dental training in 
10 
controlled prescription abuse, diversion, addiction and pain management was very 
limited. This group of health professionals rarely discussed the risks of addiction 
with patients. Dentists are not knowledgeable about laws and regulations on what 
actions to take if a patient or colleague is suspected of diversion.19 A British study of 
115 general practice physicians determined that whether or not opioids were 
prescribed for persistent non-cancer pain was mainly determined by the doctor's 
personal beliefs about appropriateness of opioids for this problem.30 In 2010, a 
survey representing 33% of West Virginia dentists and their prescribing practices, 
the Tufts Health Care Institute Program on Opioid Risk Management.· The Role of 
Dentists in Preventing Opioid Abuse was conducted. The findings illustrate that 360/0 
of dentists did not ask new patients about a history of substance abuse yet 760/0 of 
dentists estimated that between 1 % and 20% of their patient population were 
substance abusers.2, 16 
In light of the prescription opioid epidemic!, its financial burden, increasing 
number of new users, high percent of Americans with a history of substance 
dependence or abuse and the role of dentists in prescribing opioids, it is necessary 
to investigate the handling practices of patients with a personal or family history of 
addiction with respect to their opioid prescriptions. 
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MATERIALS AND METHODS 
Participants 
Opioid analgesics were prescribed to 62 adult outpatients treated at either 
an academic pain man.agement clinic or the Medical University of South Carolina 
Post-Doctoral Periodontic programs. Institutional review board (IRB) approval, 
HR#20520, was attained for each clinic. The periodontal patients were screened by 
phone interview to determine their interest in participation and were then 
scheduled for informed consent by the research assistant prior to their surgical 
appointments for which they were prescribed the opioid analgesic. Interested 
patients then met with the research assistant in a private office to discuss the study, 
evaluate inclusion criteria, and answer any questions patients may have had 
regarding participation. Inclusion criteria included: (1) patient age between 21 and 
80; (2) patient of record at one of the participating clinics; (3) a prescription opioid 
medication prescribed at the appointment; (4) accessible for follow-up via 
telephone; and (5) cognitively and physically capable to complete the web-based 
intervention. Eligible patients were given a full description of the study and asked to 
read and sign an IRB-approved informed consent form before any study procedures 
occurred. Ineligible patients were referred for treatment-as-usual. 
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Procedures 
Consenting participants re.mained in a private office and completed the Script 
Safety intervention on an internet-connected laptop computer. The intervention 
included answering questions about the participant's demographics, history of 
familial or personal drug use (See Appendix D), knowledge of appropriate 
prescription medication storage, use and disposal of prescription medications, and 
an interactive video addressing proper storage, use and disposal of prescription 
medications. The Script Safety website was accessed by the research assistant who 
indicated the specific opioid medication that the participant was prescribed which 
specifically tailored the program to that medication. Participants listened to the 
program through headphones. At one-week and one-month post intervention, the 
research assistant contacted participants via telephone to assess knowledge change 
and/or retention, medication misuse behaviors, and patient satisfaction. 
Participants received $10 gift cards for completing the Script Safety intervention, 
$15 for the one-week follow-up and $20 for the one-month follow-up. 
Study Intervention 
Script Safety as described by Back et. al. 31 is a brief, interactive, patient-
tailored, web-based intervention designed to provide patient education regarding 
the hazards of prescription opioid misuse, and ways to safely use, store and dispose 
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of prescription opioids. It is easy to understand and uses engaging multimedia 
formats to convey the information. The following components are included in the 
Script Safety program: (1) assessment of demographics and opioid medication 
misuse risk factors; (2) pre-intervention assessment of knowledge regarding 
appropriate use, storage and disposal of prescription opiods; (3) interactive 
educational program including a "Video Doctor" consultation reviewing the risks, 
and proper handling and disposal of the patient's specific opioid medication; (4) 
post-intervention assessment of knowledge to measure comprehension of material 
and provide immediate corrective feedback; and (5) a personalizable handout 
highlighing key learning points and risk reduction strategies.31 
Statistical Analyses 
The primary aim of this study was to compare those patients with a self-
reported personal or family history of substance abuse with regard to their self-
reported risk behavior and risk knowledge at baseline as well as risk knowledge at 
immediate post-intervention assessment with patients who did not have a personal 
or familial history of substance abuse. Chi-square and univariate Analysis of 
Variance (AN OVA) were conducted using SPSS (v. 17) statistical software. Alpha 




As shown in Appendix A, the mean age of participants was 58 years old, most 
were Caucasian (77.4%) and unemployed (59.70/0). A higher percentage of 
unemployment was found among participants at the pain clinic compared to 
participants at the dental clinic (p=0.004). No other significant differences in 
demographic characteristics were found. Almost half (45.20/0) of the sample 
reported a family history of addiction and 11.30/0 reported a personal history of 
addiction. Approximately 100/0 of participants indic~ted that they were living with 
someone who had a current or lifetime history of addiction. Accounting for the 
overlap of these categories, 48.40/0 (N =30) of participants qualified for a positive 
personal or familial history of addiction (see Appendix B). There appeared to be no 
difference between clinics with respect to patients reporting a personal or familial 
history of addiction. 
Medication Misuse Behaviors and Pre-Intervention Knowledge of Participants with a 
Positive Personal or Familial History of Addiction 
Participants with a positive personal or familial history of addiction were 
more likely than chance to lend their prescriptions to other people (X2 [1,62] =7.28, 
p<O.Ol). These participants were also more likely to borrow pills from other people 
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(x2 [1,62]=7.28, p<0.01). There was no significant difference with respect to their 
taking more of their opioid than prescribed (X2 [1,62]=1.99, ns), nor were they more 
likely than chance to take their medication for reasons other than prescribed 
(X 2 [1,62]=1.21, ns). These patients were neither more likely to report saving 
unused medication (X2 [1,62]=0.83, ns) nor securing medications from illicit sources 
(X2 [1,62]=1.08, ns) than participants without any addiction history (See Appendix 
C). 
A trend toward significance was elucidated with respect to pre-intervention 
knowledge regarding the best place to store medication, among those with a 
positive personal or familial history of addiction, who were more likely to answer 
incorrectly (X2 [1,62]=3.28, p=0.07). There was also a trend toward a significant 
difference in pre-intervention knowledge regarding lending pills to family or friends 
(X2 [1,62]=3.63, p=0.07) with those positive for abuse history being at increased 
likelihood of responding incorrectly. No significant differences in pre-intervention 
knowledge regarding saving unused pills (X2 [1,62]=0.39, ns), borrowing pills (X2 
[1,62]=2.61, ns), disposal of unused pills (X2 [1,62]=0.63, ns) or using expired 
medication (X2 [1,62]=0.56, ns) was found. Addiction history did not have a 
significant effect with regard to the number of correct answers on pre-intervention 
knowledge test (F(1,60)=2.S6, ns). 
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Post-Intervention Knowledge and Medication Misuse Behaviors of Participants 
with a Positive Personal or Familial History of Addiction 
Subsequent to completing the intervention, the only trend that could be 
elucidated among participants with a positive personal or familial history of 
addiction with regard to post-intervention knowledge was a difference in the proper 
disposal of prescription medications such that participants with a personal or family 
history of substance abuse were more likely to answer disposal questions 
incorrectly (X2 [1,62]=3.67, p=0.05S). No significant differences were found in 
post-intervention knowledge of storage (X2 [lJ62]=O.OO, ns), saving unused 
medications(x2 [1,62]=1.08, ns), or in keeping expired medications (X2 [1,62]=0.02, 
ns). Addiction history did not have a significant effect with regard to the number of 
correct answers on post-intervention knowledge test (F(1,60)=2.S6J ns). 
A knowledge change variable was calculated to reflect knowledge change 
from pre-intervention to post-intervention. Utilizing this variable, there was a trend 
toward a significant effect of addiction history on the change in knowledge from 
pre-intervention to post-intervention (F(l,60)=3.65, p=O.06). Patients with a 
personal or familial history of substance abuse did not demonstrate as much of a 
change in knowledge score as patients without a history. 
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DISCUSSION AND CONCLUSION 
The significant findings of this research indicate that patients with a personal 
or familial history of addiction lend and/or borrow prescription opioids more often 
than patients without a personal or familial history of addiction. These findings are 
consistent with current research in the literature. Historically, studies have 
supported the expectation that people with pre-existing substance use disorders 
and/or legal problems related to substance use are at a higher risk for prescription 
opioid misuse.32 A study of 15,160 veterans determined a diagnosis of non-opioid 
substance abuse disorder was the strongest predictor of prescription opioid abuse 
or dependence.33 Another study of 98 patients with chronic non-cancer related pain 
found that a lifetime history of substance use disorder was predictive of 
prescription opioid abuse behavior.34 
Due to the small sample size (N=62), the power to detect a difference 
between the two groups, those with a personal or familial history of addiction and 
those without} was relatively low with only a 35% chance of finding an effect. This 
could mean either that there is no difference between these groups or that the 
difference is too small to detect with this sample size. One way to overcome this 
would be to conduct a Script Safety study among patients with a known history of 
addiction, such as those affiliated with a treatment center. This would help to 
eliminate another shortcoming of this study, that of not implementing a gold 
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standard for history of substance abuse such as urine screening tests or a validated 
screening questionnaire such as the Prescription Drug Use Questionnaire (PQUD). 
The classification of a participant having a personal or family history of substance 
abuse was determined by responses to ten questions in the Script Safety 
questionnaire (see Appendix 0). 
Determining the stage of addiction was not attempted either; this may 
influence different behavioral patterns. Patients still abusing substances would 
likely misuse prescription medications more readily than patients who are in some 
stage of recovery. Those in recovery from addictions are encouraged to increase 
their recovery activities as this supports the safer use of therapeutic opioids and 
decreases the risk that such use might trigger a relapse.35 
Additionally, the small sample number of only 62 participants potentially 
may have been skewed by participation/volunteer bias meaning those willing to 
participate might not be representative of a substance abuse population. 
It is known that certain patients who are given an opioid prescription may 
misuse the opioids because of biologic and environmental susceptibility factors such 
as a family history of addiction.36 In a study of 145 patients taking opioids for 
chronic pain, those with a family history of substance abuse, a history of legal 
problems and drug or alcohol abuse had a tendency toward more aberrant drug-
related behaviors.36 A screening tool, the Prescription Drug Use Questionnaire 
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(PDUQ), developed to identify patients with addiction and problematic substance 
use was tested for efficacy on 52 subjects. While this tool is geared toward use by 
trained mental health professionals, the findings are useful for the dental 
community in that Compton et al. found that patients who have a positive addiction 
status are more likely to seek limited care from the dental community, to take 
analgesics of family members, to supplement with alcohol and other drugs and to 
visit the emergency department for analgesics.37 It is important to remember that 
not all patients with a personal or family history of addiction will misuse opioids, of 
the 52 participants in the previous study, 27% with personal history of addiction 
and 500/0 of those with a family history of addiction, used opioid analgesics in an 
appropriate manner.37 The Current Opioid Misuse Measure (COMM) is a 17-
question self-report measure regarding current aberrant drug-related behavior that 
appears promising in identification of patients at risk.38 
Prescribing recommendations for treating acute pain in dentistry have been 
set forth for treating patients with a history of substance abuse.39 These include 
asking new patients about their history of addiction or substance abuse including 
alcohol. Six to 10 % of the general population has attended Alcoholics Anonymous, 
which translates into the need for dentists to be comfortable treating acute pain in 
patients with alcoholism.27 If the patient is in recovery, then the recovery team 
should be contacted as to the best ways to manage the controlled substance; often 
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times a trusted other will take responsibility for managing the patient's medications. 
Encouraging a patient in recovery to intensify involvement in their recovery 
program before and after any dental treatment that may result in postoperative pain 
is recommended.27 As for the dosing intervals, when ibuprofen and acetaminophen 
are inadequate for alleviating postoperative pain, it is recommended that dentists 
prescribe around-the-clock opioid administration for the first 24 hours (in 
moderate pain) or the first 48 hours (in severe pain) rather than on an lias needed" 
basis.27,39 Current recommendations for dentists treating anticipated 
postoperative pain relief in patients who can toler~te non-steroidal anti-
inflammatory drugs (NSAIDS) include 200-600 mg of ibuprofen 4-6 hours for the 
first 24 hours for mild to moderate pain. If pain relief is inadequate, then 500 mg 
acetaminophen can be added every 6 hours. For severe pain, 650 mg 
acetaminophen with 10mg hydrocodone would be added to 400-600mg of 
ibuprofen every 6 hours for the first 48 hours then followed with ibuprofen as 
needed for pain. For patients who cannot tolerate NSAIDS, acetaminophen 650-
1000 mg every 6 hours is recommended for mild to moderate pain. Ten milligrams 
of hydrocodone can be added for the first 24 hours. If pain relief continues to be 
inadequate then 650 mg of acetaminophen can be coupled with 10 mg oxycodone 
administered every 6 hours for 48 hours only. Then 650-1000mg acetaminophen 
alone taken as needed for pain should suffice.39 Postoperative pain relief will also 
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be reduced by administration of pre-operative NSAIDs and postoperative 
administration of a long acting local anesthetic such as bupivicaine. Using these 
guidelines, prescriptions would be written for eight opioid pills rather than the 
more common prescription of 20 pills.4o 
There is a need to increase awareness, education and management of 
patients with a history of substance abuse. A survey of 548 undergraduate students 
enrolled in health related studies in Australia illustrated that patients with a 
substance abuse problem are poorly regarded by the respondents; these students 
were reluctant to go out of their way for the patients and felt that their skills were 
not relevant to patients presenting with substance abuse.41 
It is important that dentists understand the contribution the dental 
profession makes toward opioid diversion and misuse. Due to the staggering 
number of opioid analgesics prescribed for postoperative dental pain, this 
community must identify patients with a personal or familial history of addiction 
and utilize resources to ensure their safe handling of these prescriptions. Educating 
all patients who receive an opioid analgesic in safe storage, use and disposal of their 
prescriptions will permit fewer drugs to be diverted. Explaining the risks to 
patients, offering the Script Safety interactive video to patients and increasing the 
knowledge base for both patients and practitioners may have a profound effect on 
decreasing the misuse of prescription opioids. The drug dealer on the street corner 
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has taken a back seat to the medicine cabinet in the bathroom as a source for 
misused and abused substances. Dental and medical education needs to increase 
efforts to properly prepare graduates for identification, referral and proper 
treatment strategies for patients with a history substance abuse. 
The Script Safety interactive video was very effective at educating patients in 
the proper storage, use and disposal of their prescription opioids. A similar 
interactive video may be a useful tool to educate dental professionals either in their 
pre-doctoral training, post-doctoral residencies or as a form of continuing 
education. 
The findings of this study ill ustrate that patients with a personal or familial 
history of substance abuse are more likely to lend and/or borrow medications. 
Therefore, identification of these patients is essential for the dental community to 
offer proper counseling and prescribing practices tailored to their individual needs. 
In doing so, it is likely that fewer drugs will be diverted. 
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Family history of addiction 
Personal history of 
addiction 













































riske 2 (6.7) 4 (12.5) 6 (9.7) 0.67 
aM(SD) = Mean(Standard Deviation). Analyzed by analysis of variance. All others by 
y}. 
bSelf-identified by patients. Assessed to examine potential differences in 
demographic characteristics across settings. 
eDefined as having a current or lifetime substance use problem. 
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Appendix B: Family or Personal History of Addiction 
Family or personal history 
Addiction 
No Addiction 
48.4% of participants reported a personal, household or family history of addiction 
2S 
Appendix C: Medication Misuse Behaviors Among Participants with and without a 
history of addiction 
Medication Misuse Behaviors 
Lend 
Borrow 
Secure drugs for illicit 
sources 
Take prescriptions for other 
reasons 
Take more than prescribed 
Save unused 
~ a ~ a ~ a 
0 0 0 
0 0 0 
0 0 0 
~ ~ ~ a ~ 
0 0 0 0 
0 0 0 0 










No Addiction History 
Addiction History 
Appendix D: Questions related to personal or familial history of substance abuse. 
1. Has anyone in your household ever had .. or do they currently have, a problem 
with alcohol or drug use (e.g., marijuana, cocaine, pills, etc)? 
Yes 
No 
2. Is there a history of alcohol or drug abuse in your family, even among your 
grandparents, aunts, cousins or uncles? 
Yes 
No 
3. Have you ever had a problem with alcohol or drugs (e.g., alcohol, marijuana, 
cocaine, pills, etc)? 
Yes 
No 
Please check all that apply. In the past, when you have been prescribed a pill by a 
doctor, did you ever: 
4. Lend some of your pills, even one pill, to someone else who needed it? 
Yes 
No 
1 2 3 4 5 
Once A Few Times Several Times Regularly 




1 2 3 4 5 
Once A Few Times Several Times Regularly Often 
6 .. Take more pills than your doctor told you to, or take the pills more often than 
your doctor told you to? 
Yes 
No 
1 2 3 4 5 
Once A Few Times Several Times Regularly Often 
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7. Use your pills for other reasons than what it was prescribed (e.g., to help you 
sleep better, to improve your mood, to relieve stress, to calm your nerves)? 
Yes 
No 
1 2 3 4 5 
Once A Few Times Several Times Regularly 
8. Save your unused pills in case you needed them later? 
Yes 
No 
1 2 3 4 




9. Have to get pills from more than one doctor in order to have enough, or get them 
from non-medical sources (e.g., other than my doctor, on the street)? 
Yes 
No 
1 2 3 4 5 
Once A Few Times Several Times Regularly Often 
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